Octanoic acid

CAS No. 95809-78-2

Octanoic acid( CPI-613 )

Catalog No. M16844 CAS No. 95809-78-2

CPI-613, a lipoate analog, inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase, disrupts tumor cell mitochondrial metabolism.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 49 In Stock
10MG 58 In Stock
25MG 101 In Stock
50MG 129 In Stock
100MG 170 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Octanoic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    CPI-613, a lipoate analog, inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase, disrupts tumor cell mitochondrial metabolism.
  • Description
    CPI-613, a lipoate analog, inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase, disrupts tumor cell mitochondrial metabolism. Phase 2.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CPI-613
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Dehydrogenase
  • Recptor
    α-ketoglutarate dehydrogenase| PDH
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    95809-78-2
  • Formula Weight
    388.59
  • Molecular Formula
    C22H28O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:78 mg/mL (200.72 mM); Ethanol:78 mg/mL (200.72 mM); Water:<1 mg/mL (<1 mM)
  • SMILES
    O=C(O)CCCCC(SCC1=CC=CC=C1)CCSCC2=CC=CC=C2
  • Chemical Name
    6,8-bis(benzylthio)octanoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zachar Z, et al. J Mol Med (Berl). 2011, 89(11), 1137-1148.
molnova catalog
related products
  • WAY-311610

    WAY-311610 is an 11β-hydroxysteroid dehydrogenase HSD11B1 inhibitor that inhibits the 11β-HSD1 enzyme with an IC = 0.34 μM.It can be used to study neuropathic pain, inflammatory pain, and occipital neuralgia.

  • LDH-IN-1

    LDH-IN-1 is a novel pyrazole-based inhibitor of human lactate dehydrogenase (LDH) with IC50s of 32 and 27 nM for LDHA and LDHB, respectively.?LDH-IN-1 inhibits the growth of MiaPaCa2 pancreatic cancer and A673 sarcoma cells with IC50s of 2.23 and 1.21 μM).

  • AGI-6780

    AGI-6780 is a potent and selective inhibitor of IDH2 R140Q mutant with IC50 of 23 nM.